AXSM logo

Axsome Therapeutics (AXSM) Long Term Debt

Annual Long Term Debt

$189.70 M
+$4.59 M+2.48%

December 31, 2024


Summary


Performance

AXSM Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAXSMbalance sheetmetrics:

Quarterly Long Term Debt

$189.70 M
+$306.00 K+0.16%

December 31, 2024


Summary


Performance

AXSM Quarterly Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAXSMbalance sheetmetrics:

Long Term Debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

AXSM Long Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+2.5%+2.5%
3 y3 years+286.4%+2.5%
5 y5 years+994.5%+994.5%

AXSM Long Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+286.4%at high+286.4%
5 y5-yearat high+994.5%at high+1280.2%
alltimeall timeat high+5141.2%at high+5141.2%

Axsome Therapeutics Long Term Debt History

DateAnnualQuarterly
Dec 2024
$189.70 M(+2.5%)
$189.70 M(+0.2%)
Sep 2024
-
$189.39 M(+0.1%)
Jun 2024
-
$189.18 M(+0.8%)
Mar 2024
-
$187.64 M(+1.4%)
Dec 2023
$185.10 M(+96.4%)
$185.10 M(-0.0%)
Sep 2023
-
$185.14 M(+0.4%)
Jun 2023
-
$184.36 M(+24.9%)
Mar 2023
-
$147.62 M(+56.6%)
Dec 2022
$94.26 M(+92.0%)
$94.26 M(+0.4%)
Sep 2022
-
$93.91 M(+0.5%)
Jun 2022
-
$93.46 M(+89.5%)
Mar 2022
-
$49.31 M(+0.5%)
Dec 2021
$49.09 M(+0.4%)
$49.09 M(-0.2%)
Sep 2021
-
$49.17 M(+0.4%)
Jun 2021
-
$48.96 M(+0.1%)
Mar 2021
-
$48.93 M(+0.0%)
Dec 2020
$48.90 M
$48.90 M(+1.8%)
DateAnnualQuarterly
Sep 2020
-
$48.03 M(+249.4%)
Jun 2020
-
$13.74 M(-11.6%)
Mar 2020
-
$15.54 M(-10.3%)
Dec 2019
$17.33 M(+378.9%)
$17.33 M(-9.3%)
Sep 2019
-
$19.11 M(+9.7%)
Jun 2019
-
$17.42 M(-7.4%)
Mar 2019
-
$18.82 M(+419.9%)
Dec 2018
$3.62 M(-45.7%)
$3.62 M(-18.5%)
Sep 2018
-
$4.44 M(-14.5%)
Jun 2018
-
$5.19 M(-12.5%)
Mar 2018
-
$5.93 M(-11.0%)
Dec 2017
$6.66 M(-29.6%)
$6.66 M(-9.7%)
Sep 2017
-
$7.38 M(-8.7%)
Jun 2017
-
$8.08 M(-8.0%)
Mar 2017
-
$8.78 M(-7.3%)
Dec 2016
$9.47 M(+113.2%)
$9.47 M(-13.2%)
Jun 2015
-
$10.91 M(+145.6%)
Dec 2014
$4.44 M
$4.44 M

FAQ

  • What is Axsome Therapeutics annual long term debt?
  • What is the all time high annual long term debt for Axsome Therapeutics?
  • What is Axsome Therapeutics annual long term debt year-on-year change?
  • What is Axsome Therapeutics quarterly long term debt?
  • What is the all time high quarterly long term debt for Axsome Therapeutics?
  • What is Axsome Therapeutics quarterly long term debt year-on-year change?

What is Axsome Therapeutics annual long term debt?

The current annual long term debt of AXSM is $189.70 M

What is the all time high annual long term debt for Axsome Therapeutics?

Axsome Therapeutics all-time high annual long term debt is $189.70 M

What is Axsome Therapeutics annual long term debt year-on-year change?

Over the past year, AXSM annual long term debt has changed by +$4.59 M (+2.48%)

What is Axsome Therapeutics quarterly long term debt?

The current quarterly long term debt of AXSM is $189.70 M

What is the all time high quarterly long term debt for Axsome Therapeutics?

Axsome Therapeutics all-time high quarterly long term debt is $189.70 M

What is Axsome Therapeutics quarterly long term debt year-on-year change?

Over the past year, AXSM quarterly long term debt has changed by +$4.59 M (+2.48%)